Short and Long Term Clinical and Patient-Reported Outcomes Associated With Intragastric Balloon Placement in Patients With Nonalcoholic Fatty Liver Disease
Part of paid clinical trials in Dallas, Texas.
- Sponsor
- Methodist Health System
- Study ID
- NCT07493967
- Status
- Enrolling By Invitation
Conditions
- NAFLD
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
This study aims to enroll a robust cohort of NAFLD patients who undergo Intragastric Balloon placement through a multidisciplinary program approach to evaluate clinical and patient-reported outcomes for at least one-year post-placement.
Key Dates
- Start date
- Feb 23, 2024
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2026
- Completion
- Feb 28, 2027
Study Design
- Enrollment
- 200 participants (estimated)
Primary Outcome Measure
Changes in Weight [ Time Frame: through study completion, up to 18 months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Methodist Dallas Medical Center | Dallas | Texas | 75203 | - |
Find similar trials in Dallas, TX
By research site
Related Studies
- NAFLD Clinical Care PathwayRecruiting · VA Office of Research and Development · Houston, Texas
- Reversal of Lipid-Induced Insulin ResistanceRecruiting · Yale University · New Haven, Connecticut
- Bariatric Embolization of Arteries for the Treatment of Nonalcoholic SteatohepatitisNot Yet Recruiting · Keith Pereira, MD: · St Louis, Missouri
- SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver DiseasePHASE2 · Not Yet Recruiting · Justin Ryder · Chicago, Illinois